Antibodies
X
brain
ABXBRAIN is changing the game in treating brain cancer with a therapeutic product capable of crossing the Blood-Brain Barrier and targeting PD-1 on T cells.
Pipeline: BFP-B3T-001
We are working toward an Antibody-Drug Conjugate capable of crossing the Blood-Brain Barrier (BBB) and targeting PD-1 on T-Cells.
Rapid Evolution
We know how important it is to be fast. That’s why we iterate our models through transient Nicotiana benthamiana expression, allowing for infiltration to sample collection timelines of a matter of days.
Using this cheap expression platform and making adjustments allows for massive potential to quickly learn and optimize our design, with a glycosylation profile similar to that of mammalian antibodies but able to increase molecular half-life.
People
ABXBRAIN has a team of researchers that relentlessly strive toward our goal of a treatment for brain cancer. Our leaders:
Noah
Machakos
Noah goes hard every day to deliver results
Waranyoo
Phoolcharoen
Waranyoo is the genius behind everything
Suthira Taychakhoonavudh
Suthira has tremendous willpower
Jompong Champaiboon
Jompong brings deep industry knowledge